| Molecular Genetics Studies of Cancer Patients and Their RelativesNCT04185935 · Phoenix, Arizona | — | 35 |
| Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care GiversNCT06524973 · Arcadia, California | Not applicable | 22 |
| Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their CaregiversNCT06196008 · Davis, California | Not applicable | 16 |
| Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer PatientsNCT07125729 · Goodyear, Arizona | Not applicable | 13 |
| Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP TrialNCT07288034 · Goodyear, Arizona | Phase 2 | 13 |
| A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 DiabetesNCT07061574 · San Francisco, California | Phase 1/2 | 11 |
| A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma PatientsNCT07225738 · Goodyear, Arizona | — | 11 |
| Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3NCT07595874 · Goodyear, Arizona | Phase 2 | 11 |
| A Study on the Effects of Exercise Therapy on Signs of Prostate CancerNCT05751434 · Durate, California | Phase 2 | 10 |
| A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care MogamulizumabNCT07003100 · Duarte, California | — | 10 |
| Pancreatic Cancer Detection ConsortiumNCT06388967 · Phoenix, Arizona | — | 9 |
| Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple MyelomaNCT04508790 · Duarte, California | Phase 2 | 8 |
| Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaNCT06918431 · Phoenix, Arizona | Phase 2 | 8 |
| Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast CancerNCT06954831 · Arcadia, California | Phase 2 | 7 |
| Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity TrialNCT07218510 · Duarte, California | Phase 2 | 7 |
| Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.NCT04305834 · Duarte, California | Phase 2 | 6 |
| Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell LymphomaNCT03011814 · Duarte, California | Phase 1/2 | 4 |
| Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell LymphomaNCT03523975 · Duarte, California | Phase 1/2 | 4 |
| L-Theanine to Support Relaxation and Mood for Cancer Patients in SurveillanceNCT07220447 · Duarte, California | Early phase 1 | 4 |
| Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid CancerNCT03975231 · Duarte, California | Phase 1 | 3 |
| PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric CancerNCT04329494 · Duarte, California | Phase 1 | 3 |
| CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in ChildrenNCT04510051 · Duarte, California | Phase 1 | 3 |
| Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell LymphomaNCT04930653 · Scottsdale, Arizona | Phase 2 | 3 |
| AOH1996 for the Treatment of Refractory Solid TumorsNCT05227326 · Scottsdale, Arizona | Phase 1 | 3 |
| Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell LymphomaNCT05861050 · Duarte, California | Phase 1/2 | 3 |
| Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S TrialNCT06022965 · Duarte, California | Not applicable | 3 |
| Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY TrialNCT06042569 · Duarte, California | Phase 2 | 3 |
| CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell TransplantNCT06059391 · Duarte, California | Phase 2 | 3 |
| Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation TherapyNCT06139627 · Duarte, California | Not applicable | 3 |
| Denosumab for Type 1 DiabetesNCT06524960 · Birmingham, Alabama | Phase 1/2 | 3 |
| Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing ChemotherapyNCT06763328 · Duarte, California | Phase 3 | 3 |
| A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell TransplantNCT07020533 · Duarte, California | Phase 1 | 3 |
| Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell LymphomaNCT07365306 · Duarte, California | Phase 2 | 3 |
| Enasidenib (AG-221) Maintenance Post Allogeneic HCT in Patients With IDH2 MutationNCT03728335 · Duarte, California | Phase 2 | 2 |
| Phase II Trial of Lung ChemoemobolizationNCT05672108 · Duarte, California | Phase 2 | 2 |
| Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung CarcinomaNCT06014827 · Duarte, California | Phase 2 | 2 |
| Carfilzomib in Combination With Sotorasib for the Treatment of Patients With KRAS G12C Mutated Advanced or Metastatic Non-small Cell Lung CancerNCT06249282 · Duarte, California | Phase 1 | 2 |
| Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast CancerNCT06260033 · Duarte, California | Phase 2 | 2 |
| Early Detection of Advanced Adenomas and Colorectal CancerNCT06342440 · Monrovia, California | — | 2 |
| Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular LymphomaNCT06453044 · Duarte, California | Phase 2 | 2 |
| Comparing the Impact of Four Types of Meditation Practices for Relaxation in Cancer SurvivorsNCT06500377 · Duarte, California | Not applicable | 2 |
| Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell TransplantNCT06543381 · Duarte, California | Phase 1 | 2 |
| Nemtabrutinib With Rituximab for the Treatment of Patients With Mantle Cell LymphomaNCT06572618 · Duarte, California | Phase 2 | 2 |
| Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer SurvivorsNCT06731894 · Duarte, California | Phase 2 | 2 |
| Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung CancerNCT06910761 · Duarte, California | Phase 2 | 2 |
| Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After SurgeryNCT07037004 · Duarte, California | Phase 2 | 2 |
| Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell CancerNCT07128680 · Duarte, California | Phase 1 | 2 |
| Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid NodulesNCT03676647 · Duarte, California | — | 1 |
| Improving Islet Transplantation Outcomes With Gastrin for Type I DiabetesNCT03746769 · Duarte, California | Phase 1/2 | 1 |
| Modified Immune Cells (CD19 CAR T Cells) and Acalabrutinib for the Treatment of Relapsed or Refractory Mantle Cell LymphomaNCT04484012 · Duarte, California | Phase 2 | 1 |
| Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29NCT04670874 · Duarte, California | — | 1 |
| Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate CancerNCT04734730 · Duarte, California | Phase 2 | 1 |
| Study to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therapy in Patients With Prostate CancerNCT04775355 · Duarte, California | — | 1 |
| Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin LymphomaNCT04871607 · Duarte, California | Phase 2 | 1 |
| Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast CancerNCT04913064 · Duarte, California | Not applicable | 1 |
| Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic CancersNCT05204147 · Duarte, California | Phase 1 | 1 |
| Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian CancerNCT05225363 · Duarte, California | Phase 1 | 1 |
| Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid NodulesNCT05229341 · Duarte, California | Not applicable | 1 |
| 8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid LeukemiaNCT05263284 · Duarte, California | Phase 1 | 1 |
| Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal MetastasesNCT05285358 · Duarte, California | Phase 1 | 1 |
| Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple MyelomaNCT05363111 · Duarte, California | Phase 1 | 1 |
| Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)NCT05371132 · Duarte, California | Phase 1 | 1 |
| An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain MetastasisNCT05376878 · Duarte, California | Phase 4 | 1 |
| Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung CancerNCT05384769 · Duarte, California | Not applicable | 1 |
| Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin LymphomaNCT05432635 · Duarte, California | Phase 1 | 1 |
| Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic MalignanciesNCT05443425 · Duarte, California | Phase 1 | 1 |
| Circulating Biomarkers in the Development of Type 1 DiabetesNCT05505669 · Duarte, California | — | 1 |
| Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary CancersNCT05519878 · Duarte, California | Not applicable | 1 |
| CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid LeukemiaNCT05672147 · Duarte, California | Phase 1 | 1 |
| Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell LymphomaNCT05672251 · Duarte, California | Phase 2 | 1 |
| Spatiotemporal Stereotactic Body Radiation Therapy for the Treatment of Patients With Polymetastatic Solid TumorsNCT05733949 · Duarte, California | Not applicable | 1 |
| Provider-Mediated Communication of Genetic Testing Results to At-Risk Relatives of Cancer Patients to Improve Genetic Counseling and Testing Rates, Family HOPE StudyNCT05772130 · Duarte, California | Not applicable | 1 |
| Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell LymphomaNCT05800405 · Duarte, California | Early phase 1 | 1 |
| Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) for the Treatment of Intermediate or High Grade B-Cell Non-Hodgkin LymphomaNCT05801913 · Duarte, California | Phase 1 | 1 |
| PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate CancerNCT05805371 · Duarte, California | Phase 1 | 1 |
| Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell CarcinomaNCT05830058 · Duarte, California | Phase 2 | 1 |
| Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination TherapyNCT05869682 · Duarte, California | Phase 2 | 1 |
| Mezigdomide (CC-92480) Post Idecabtagene Vicleucel in Treating Patients With Relapsed Multiple MyelomaNCT06048250 · Duarte, California | Phase 1 | 1 |
| Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART StudyNCT06052826 · Duarte, California | Phase 2 | 1 |
| Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory Mantle Cell LymphomaNCT06054776 · Duarte, California | Phase 2 | 1 |
| Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic SyndromeNCT06128070 · Duarte, California | Phase 2 | 1 |
| Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast CancerNCT06130826 · Duarte, California | Phase 1 | 1 |
| Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic SyndromeNCT06195891 · Duarte, California | Phase 1 | 1 |
| 225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic SyndromeNCT06287944 · Duarte, California | Phase 1 | 1 |
| Stage II/III Colorectal Cancer RecurrenceNCT06314958 · Monrovia, California | — | 1 |
| Early Onset Colorectal Cancer DetectionNCT06342401 · Duarte, California | — | 1 |
| An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver CancerNCT06342414 · Duarte, California | — | 1 |
| Risk Assessment Evaluation for Identifying Participants at High Risk for Stomach CancerNCT06408220 · Duarte, California | Not applicable | 1 |
| Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E MutationNCT06440850 · Duarte, California | Phase 2 | 1 |
| Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic CancerNCT06454383 · Duarte, California | Phase 1 | 1 |
| Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell TransplantNCT06498973 · Duarte, California | Phase 1 | 1 |
| Telehealth Intervention for Ostomy Self-ManagementNCT06528990 · Duarte, California | Phase 2 | 1 |
| Biology-Guided Radiation Therapy for the Treatment of Patients With Bone MetastasesNCT06549478 · Duarte, California | Phase 1 | 1 |
| External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients With Extramedullary DiseaseNCT06572605 · Duarte, California | Phase 1/2 | 1 |
| Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell TransplantNCT06575296 · Duarte, California | Phase 1 | 1 |
| Pacritinib in Combination With a BTK Inhibitor for the Treatment of Patients With Relapsed or Refractory Mantle Cell LymphomaNCT06675123 · Duarte, California | Phase 1 | 1 |
| Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal MetastasesNCT06675136 · Duarte, California | Phase 1 | 1 |
| Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic LeukemiaNCT06735690 · Duarte, California | Early phase 1 | 1 |
| A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid LeukemiaNCT06763341 · Duarte, California | Phase 1 | 1 |
| FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before SurgeryNCT06780787 · Duarte, California | Phase 2 | 1 |
| Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity ConditioningNCT06815003 · Duarte, California | Phase 2 | 1 |
| Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant AstrocytomaNCT06815029 · Duarte, California | Phase 1 | 1 |
| Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE TrialNCT06834126 · Duarte, California | Phase 1 | 1 |
| Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin LymphomaNCT06859008 · Duarte, California | Phase 1 | 1 |
| Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast CancerNCT06860815 · Duarte, California | Phase 2 | 1 |
| Virtual Reality Interventions for the Improvement of Depression, Anxiety and Pain in Patients With Head and Neck Cancer and CaregiversNCT06985784 · Duarte, California | Not applicable | 1 |
| Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell TransplantNCT06996119 · Duarte, California | Phase 1 | 1 |
| Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell TransplantationNCT07025538 · Duarte, California | Phase 1 | 1 |
| Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T CellsNCT07042438 · Duarte, California | Phase 2 | 1 |
| Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic LeukemiaNCT07133997 · Duarte, California | Phase 1 | 1 |
| Different Types of Massage Therapy to Reduce Anxiety During Chemotherapy Infusion in Patients With CancerNCT07184294 · Irvine, California | Not applicable | 1 |
| Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) TherapyNCT07186192 · Duarte, California | Phase 3 | 1 |
| Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT TrialNCT07202247 · Duarte, California | Phase 2 | 1 |
| Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R)NCT07210086 · Duarte, California | Phase 2 | 1 |
| Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane ChemotherapyNCT07218718 · Duarte, California | Not applicable | 1 |
| Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell TumorsNCT07218913 · Duarte, California | Phase 1 | 1 |
| 177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate CancerNCT07219147 · Duarte, California | Phase 1 | 1 |
| Exosome-derived Extrahepatic Metastasis Detection By Liquid Biopsy In Colorectal Cancer Liver MetastasesNCT07224724 · Duarte, California | — | 1 |
| A Noninvasive and Screening miRNA Signature for Gastrointestinal CancerNCT07224750 · Duarte, California | — | 1 |
| Liquid Biopsy for Early Detection of Colorectal Cancer Using Circular RNANCT07224789 · Duarte, California | — | 1 |
| cfDNA 5mC/5hmC Biomarkers to Predict Chemotherapy Response in Metastatic Colorectal CancerNCT07224815 · Duarte, California | — | 1 |
| Development of a cfDNA 5mC/5hmC-based Biomarker Panel to Predict Targeted Therapy Efficacy in mCRCNCT07224841 · Duarte, California | — | 1 |
| Geriatric Assessment and Management for Older Adults Undergoing Chemotherapy and Radiation Therapy for Head and Neck Cancer and Their Family CaregiversNCT07225855 · Duarte, California | Not applicable | 1 |
| Splicing-based Predictive Learning for Individual Chemotherapy Evaluation in Colorectal CancerNCT07226115 · Duarte, California | — | 1 |
| Prediction of Neoadjuvant Chemotherapy Response in Pancreatic CancerNCT07226154 · Duarte, California | — | 1 |
| Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell CancerNCT07226544 · Duarte, California | Phase 2 | 1 |
| Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell TransplantationNCT07235501 · Duarte, California | — | 1 |
| Detection of Minimal Residual Disease Using Exosomal miRNA Distant Metastasis MarkersNCT07243015 · Duarte, California | — | 1 |
| An Exosomal microRNA Signature for Preoperative Staging in Colon CancerNCT07255729 · Duarte, California | — | 1 |
| Project for Multi-Omics-Based Early Detection of Hepatocellular Carcinoma (PROMETHEA Study)NCT07265271 · Duarte, California | — | 1 |
| Integrated Cf-miRNA and Exosomal miRNA Signature for Early Detection of Esophageal Squamous Cell CarcinomaNCT07266363 · Monrovia, California | — | 1 |
| Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell LymphomasNCT07278856 · Duarte, California | Phase 1 | 1 |
| Duvelisib Maintenance for the Treatment of Peripheral T-Cell LymphomasNCT07293403 · Duarte, California | Phase 2 | 1 |
| Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade GliomasNCT07544992 · Duarte, California | Phase 1 | 1 |
| Alternative Splicing Based Prediction of Chemotherapy Response in Gastric CancerNCT07587229 · Duarte, California | — | 1 |
| Molecular Profiling for Risk Stratification in Appendiceal CancerNCT07587268 · Durate, California | — | 1 |
| Individualized AML TreatmentNCT07613385 · Duarte, California | — | 1 |
| Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT TrialNCT07650656 · Duarte, California | Phase 2 | 1 |
| Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against CancerNCT07664579 · Duarte, California | — | 1 |